Macleods Pharma files IPO papers with SEBI. Details here1 min read 15 Feb 2022, 02:15 PM IST
Macleods Pharma IPO consists of an offer for sale OFS of up to 60.48 million shares, by the selling shareholders from the Promoter and Promoter Group
Macleods Pharmaceuticals Limited, one of the leading, vertically integrated, global pharmaceuticals companies in India, has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started